To Evaluate the Safety and Effectiveness of Atorvastatin... | NCT00151502 | Trialant

To Evaluate the Safety and Effectiveness of Atorvastatin... | NCT00151502 | Trialant

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
If the results of this study demonstrate efficacy and lead to the approval by the FDA of atorvastatin for use in humans for the treatment of Alzheimer's disease, this would be available as an additional treatment option for patients.

Secondary Outcomes

Measure	Description	Time Frame
If the results of this study demonstrate efficacy and lead to the approval by the Food and Drug Administration of atorvastatin for use in humans, subject activities of daily living are being assessed.

Contacts/Locations Module

Ancestor Terms

ID	Term
D003704	Dementia
D001927	Brain Diseases
D002493	Central Nervous System Diseases
D009422	Nervous System Diseases
D024801	Tauopathies
D019636	Neurodegenerative Diseases
D019965	Neurocognitive Disorders
D001523	Mental Disorders